Story perspectives
AI-Driven Virus Targets Antibiotic-Resistant E. Coli, Sparks Concerns
1/27/2026
39 6
1 of 1
Story summary
- Genyro, led by Dr. Adrian Woolfson, created Evo–?2147 using AI Evo2 to combat antibiotic-resistant E. coli.
- The virus consists of 5,386 DNA base pairs.
- The Sidewinder method boosts DNA assembly accuracy and speed in Evo–?2147's development.
- Researchers have excluded human pathogens from Evo2's training data to mitigate risks.
- Concerns about AI misuse in creating bioweapons remain.
